Consolidated Statement of Shareholders' Equity - 3 months ended Apr. 29, 2017 - USD ($)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit
Common Stock, Shares, Outstanding period beginning at Jan. 28, 2017	65,192,314	65,192,314.000
Total Shareholders' Equity period beginning at Jan. 28, 2017	$ 81,703,000	$ 652,000	$ 436,962,000	$ (355,911,000)
Net loss	(3,196,000)	$ 0	0	(3,196,000)
Repurchases of common stock, Shares		(4,400,000)
Repurchases of common stock, Value	(5,055,000)	$ (44,000)	(5,011,000)	0
Common stock issuances pursuant to equity compensation plans, Shares		75,778
Common stock issuances pursuant to equity compensation plans, Value	(5,000)	$ 1,000	(6,000)	0
Share-based payment compensation, Shares		0
Share-based payment compensation, Value	521,000	$ 0	521,000	0
Common stock and warrant issuance, Shares		100,000
Common stock and warrant issuance, Value	$ 109,000	$ 1,000	108,000	0
Common Stock, Shares, Outstanding period end at Apr. 29, 2017	60,968,092	60,968,092.000
Total Shareholders' Equity period end at Apr. 29, 2017	$ 74,077,000	$ 610,000	$ 432,574,000	$ (359,107,000)